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Background: No significant effect of psychological treatment has been reported from 
meta-analysis of subthreshold depression patients and control subjects at 1-year follow-up. 
However, behavioral activation is a simpler and more cost-effective treatment than cognitive 
behavioral therapy. The primary purpose of this study was to assess by comparison to an 
assessment-only control group whether the effects of behavioral activation program for depres-
sive symptoms can persist up to 1-year follow-up without the use of antidepressants or other 
psychotherapy.
Patients and methods: Late adolescent students were the population targeted in this study. 
Participants were allocated randomly to an intervention group (n=62) or a control group (n=56). 
Treatment consisted of five-weekly 60-minute sessions. Participants underwent a structured 
interview and completed self-report scales at 1 year post-assessment.
Results: Late adolescent students receiving treatment had significantly lower mean Beck 
Depression Inventory, second edition scores at 1-year follow-up than control group students. 
The effect size (Hedges’ g) for between-group differences at 1-year follow-up was -0.41.
Conclusion: Our behavioral activation program is simple and short. Nevertheless, the results 
obtained at 1-year follow-up of the control group and late adolescent students receiving treatment 
indicated a significant difference in their Beck Depression Inventory, second edition scores. 
Our 5-week behavioral activation program based on behavioral characteristics for subthreshold 
depression might be promising for subthreshold depression. The sample examined for this study 
imposed some study limitations.
Keywords: behavioral activation, first-year university students, randomized controlled trial, 
subthreshold depression
Introduction
Subthreshold depression is defined as the exhibition of clinically significant depressive 
symptoms that do not meet the diagnostic criteria for major depressive disorder 
(MDD).1 Subthreshold depression is a major risk factor for subsequent development 
of more severe depressive symptoms.2–5 The probability of MDD is known to increase 
steadily during adolescence, that is, 12–20 years.6 Although not meeting the full criteria, 
subthreshold depression has been associated with severe problems such as negative 
impact on academic performance and social activities,7 which might be as severe as 
those associated with full depression.8
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An earlier report described that the use of antidepressant 
medication by adolescent patients is associated with a mod-
estly increased risk of suicidality.9 It is, therefore, especially 
important to assess the effectiveness of psychological treat-
ment programs only, without antidepressants, for late ado-
lescents with subthreshold depression. Several earlier reports 
of studies with longer follow-up (1 year) have described that 
cognitive behavioral therapy (CBT) can reduce the risk of 
MDD.10–12 Nevertheless, a meta-analysis of psychological 
treatments for subthreshold depression found no significant 
effect of psychotherapy for depressive symptoms at 1-year 
follow-up13 and found no significant effect of CBT on the 
incidence of MDD at follow-up.13
For adolescent and late adolescent patients with depres-
sion, earlier reports have described behavioral activation 
as an effective treatment.14,15 For university students with 
moderately depressive symptoms, behavioral activation was 
found to have significantly greater reduction in depressive 
symptoms from pretreatment to posttreatment.16 Although 
the meta analysis of behavioral activation for children and 
adolescents reported that behavioral activation was effec-
tive from pretreatment to posttreatment, the long-term 
effect has not yet been elucidated for children and adoles-
cent patients.17 An earlier systematic review of behavioral 
activation programs for depression revealed an effect size 
of -0.35 (Hedges’ g) in comparison with control condi-
tions at 6–9 months of follow-up.18 The effectiveness of 
behavioral activation in follow-up might not have a suffi-
cient effect. No report of the relevant literature describes a 
study that examined the long-term efficacy of brief behav-
ioral activation for subthreshold depression. Recently, we 
conducted a randomized controlled trial (RCT) to examine 
the efficacy of a brief five-session behavioral activation 
program for late adolescent patients with subthreshold 
depression.19 Results demonstrated that late adolescent 
students receiving this treatment exhibited significantly 
greater improvement in self-reported depressive symptoms 
than the assessment-only control group. The effect size was 
Hedges’ g of -0.90.19 It has not been reported whether the 
effects of this behavioral activation program can be main-
tained over the long term.
Therefore, the primary purpose of this study was to 
assess whether a behavioral activation program without 
antidepressants for depressive symptom can be maintained 
for depressive symptoms up to 1 year and be compared with 
the assessment-only control group. The secondary aim was 
to explore whether the behavioral activation program can 
decrease the risk of developing MDD or not.
Patients and methods
research design
Details of the study design of this RCT were presented in 
an earlier report (UMIN000011967).19 The 1-year follow-up 
study was already planned in the original RCT. Furthermore, 
the same student sample as that examined in an earlier study19 
was followed up 1 year later in the present study.
Procedures
Details of procedures of this RCT were presented in an 
earlier report.19 Participants were recruited from Hiroshima 
University over a 2-year period during 2013–2014 (Figure 1). 
The Beck Depression Inventory, second edition (BDI-II) 
is administered annually to all first-year students of the 
university as a part of their health examination, which is con-
ducted at the Health Service Center of Hiroshima University. 
We randomly selected the first-year students with a BDI-II 
score $10 using the Microsoft Excel randomization function. 
Recruitment took place through email at a public informa-
tion sharing center. Then, we held a meeting to explain 
the study contents. After all the participants had signed a 
written informed consent form, participants received the 
Composite International Diagnostic Interview (CIDI) and 
completed self-report scales via the Internet. An expert of 
the Department of Clinical Research, who was independent 
of the research team that conducted this study, developed a 
sequential assignment list using computer-generated random 
numbers to allocate the participants to a treatment or a control 
group randomly at a 1:1 ratio. The random sequence was 
stratified by sex and depression severity during screening 
(BDI-II score #13, BDI-II score $14). The group alloca-
tion was masked in the entry and in the CIDI assessment. A 
psychiatrist interviewed the participants and assessed the risk 
of a future acute suicide attempt if a participant had a history 
of attempted suicide based on CIDI criteria. Furthermore, 
participants who met the criteria for a possible acute suicide 
attempt received counseling from a psychiatrist. Participants 
joined the RCT.19 We contacted the participants by email 
and telephone 1 year later. Participants received telephone 
interviews by CIDI and completed self-report scales via the 
Internet 1 year after the assessment by blind testers who 
did not know the allocation. In CIDI assessment of 1-year 
follow-up, allocation to the treatment group or control group 
was masked.
Participants
We recruited late adolescent students with subthreshold 
depression during a 2-year period of 2013–2014 at Hiroshima 
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enduring effects of behavioral activation
University in Japan. For this study, the inclusion criteria were 
the following: 18–19-year-old first-year university student at 
Hiroshima University, BDI-II score $10 according to earlier 
studies,20,21 participants who did not have a major depressive 
episode during the previous year as determined by the struc-
tured clinical interview with the CIDI, and not undergoing 
psychopharmacological or psychological treatment. The 
exclusion criteria were the following: a lifetime history of 
Figure 1 Study flow chart.
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bipolar disorder according to earlier studies,20–24 possibility of 
an acute suicidal attempt, difficulty understanding the study 
purpose, or having a severe physical disease and “difficulty 
in completing self-report scales”.
intervention
Our behavioral activation program consisted of five-weekly 
60-minute sessions. The program emphasized increased 
access to positive reinforcement activities to improve the 
rate of response-contingent positive reinforcement. Our 
behavioral activation program was modeled after the behav-
ioral activation component of a CBT program developed 
based on earlier studies of adult depression in the USA25,26 
and which has been demonstrated in an RCT to be effective 
for subthreshold depression in the workplace in Japan.21 
Details of intervention of this RCT can be found in an 
earlier report.19
control group
The control group participants were examined for outcome 
measures. They received baseline, posttreatment, and 
follow-up assessments at approximately the same time as 
the intervention group did. The control group participants 




The Japanese version of the BDi-ii
BDI-II consists of 21 self-report items scored on a four-point 
scale. It is used to measure depressive symptoms.27 Good 
reliability and validity have been reported for the Japanese 
version of BDI-II.28 BDI-II was administered at baseline, at 
the end of treatment, and at 1-year follow-up. The primary 
outcome of this report is BDI-II scores at 1-year follow-up. 
The internal consistencies of the BDI-II in pretreatment, 
posttreatment, and 1-year follow-up were assessed using 
Cronbach’s α. The internal consistencies for all time BDI-II 
were also acceptable: pretreatment α=0.79, posttreatment 
α=0.74, and 1-year follow-up α=0.87.
secondary outcome
composite international Diagnostic interview
The CIDI is a structured interview for assessing mental 
disorders.29 Good reliability and validity have been reported 
for the Japanese ver 3.0 of the CIDI.30 We used the Japanese 
3.0 version of the CIDI in screening and 1-year follow-up. 
We assessed for 12-month history of MDD, generalized 
anxiety disorder, panic disorder, social phobia, and post-
traumatic stress disorder. In addition, each participant was 
assessed for the lifetime history of bipolar disorder. Because 
earlier reports have described the comorbidity rate for depres-
sion and anxiety as high,31 we included generalized anxiety 
disorder, panic disorder, social phobia, and post-traumatic 
stress disorder in screening for this study.
We administered CIDI to the participants before baseline 
and at 1-year follow-up. At the follow-up assessment, we 
limited the time frame to the previous year to ascertain the 
new incidence of MDD. The secondary outcome of this report 
is the incidence of MDD during 1 year of follow-up.
sample size calculation
Sample size calculations were conducted at the study design 
stage.19
An earlier report described a mean effect size of d=0.87 
in behavioral activation group vs a control group at posttest.32 
The mean effect size found for psychotherapies for sub-
threshold depression was d=0.42.13 Because effect sizes 
suggest that d=0.5 indicates a medium effect,33 we set 
the effect size in our study as a medium effect (d=0.50). 
We estimated a minimum of 64 participants in each group 
at the study design stage (power=0.80 and α=0.05, d=0.50 
for an unpaired t-test). Therefore, the power might be insuf-
ficient to detect differences in incidence of MDD that occurs 
over 1 year.
statistical analysis
All statistical analyses were conducted using software (SPSS 
Statistics 22; IBM Corp.).
Primary outcome analysis
The primary purpose of this study was exploratory examina-
tion of whether behavioral activation program effects per-
sisted at 1-year follow-up. The primary point was estimation 
of the intervention effect on depressive symptoms between 
the original assigned groups at 1-year follow-up. Analysis 
of variance with repeated measures is limited to cases with 
complete data or with imputation of missing data. Some 
statistical approaches are useful for dealing with missing data 
that do not necessarily require formal imputation methods.34 
For example, the linear mixed model for repeated measure 
approach was used for analyzing outcomes measured repeat-
edly over time.34–36 To examine the effects of treatment on 
primary outcomes at 1-year follow-up, the primary analysis 
was conducted using a linear mixed model for repeated 
measures. The random effects of this model were intercepts. 
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Therefore, because individual differences are explained as 
a variable effect, the mode of analysis of this research is a 
model showing change from the individual baseline. The 
model predictors were categorical time (pretreatment, post-
treatment, 1-year follow-up), treatment condition, and time × 
treatment interaction as fixed effects. We applied intention-
to-treat (ITT) analysis between the original assigned groups. 
We conducted post hoc analysis if an interaction was found. 
Effect sizes were calculated and reported as Hedges’ g37 for 
between-group differences in 1-year follow-up, using the 
observed standard error (SE) at follow-up.
Some participants might not complete the full protocol of 
a longitudinal study. Sensitivity analyses can be conducted 
using different approaches to ascertain how robust the 
primary analysis is for the chosen method for handling miss-
ing data.34 For sensitivity analysis, we conducted a complete 
case analysis to assess the discrepancy between ITT and 
complete case analysis.
secondary exploratory outcome analysis
Next, we applied Cox proportional hazard analysis for 
exploratory assessment of the differences in time for the 
development of MDD between the intervention group and 
the control group to adjust for lifetime diagnosis of MDD. 
In CIDI, participants who met the criteria for MDD reported 
the time that participants developed depressive symptoms.
ethics approval
Approval for the study was obtained from the ethics com-
mittee of Hiroshima University. All participants signed a 
written informed consent form.
Results
Participant enrollment
Figure 1 presents the study flow. Of the 208 students who 
gave their informed consent to participate, 205 (98.6%) 
completed screening. The mean score of BDI-II during 
screening was 13.53. Then, the 108 participants who satis-
fied all the eligibility criteria were allocated randomly to the 
intervention or control group (Table 1). The BDI-II average 
score of the sample consisting of 118 students was 13.02. 
One intervention group participant dropped out. One control 
group participant underwent psychopharmacological or psy-
chological treatment during 5 weeks. At 1-year follow-up, 
seven intervention group participants did not complete the 
CIDI and self-report scales. Three intervention group par-
ticipants had undergone psychopharmacological or psycho-
logical treatment during the follow-up period. Five control 
group participants did not complete the CIDI and self-report 
scales. One control group participant had undergone psy-
chopharmacological or psychological treatment during the 
follow-up. Therefore, missing data of the intervention group 
were those of ten participants from posttreatment to 1-year 
follow-up. Missing data of the control group were those of 
six participants from posttreatment to 1-year follow-up. No 
significant difference was found in the rates of missing data 
(χ2 (1)=0.73, P=0.43).
Depressive symptoms (primary outcome)
results obtained from a linear mixed model
The primary point was estimation of the intervention effect on 
depressive symptoms between the original assigned groups 
at 1-year follow-up. To assess the effects of treatment on 
primary outcomes at 1-year follow-up, primary analysis was 
conducted using a linear mixed model for a repeated measures 
approach in the original assigned groups  (62 participants in 
the intervention group and 56 participants in the control 
group). Significant interaction was found between groups and 
times (F value=9.01, degrees of freedom=216.45, P,0.01; 
Figure 2). Significant difference was found between the mean 
estimates for the intervention group and the control group at 
1-year follow-up (intervention group, mean estimate=11.00, 
SE=0.89, 95% CI: 9.24 to 12.76; control group, mean 
estimate=13.83, SE=0.91, 95% CI: 12.00 to 15.61; estimated 
mean difference=2.83, 95% CI: 0.28 to 5.33, P=0.03), as 
shown in Table 2. The effect size (Hedges’ g) for between-
group differences at 1-year follow-up was -0.41 (95% CI: 
-0.77 to -0.04). Additionally, a significant difference was 
found in the mean estimates between the intervention group 
and control group at posttreatment (intervention group, mean 
estimate=7.03, SE=0.84, 95% CI: 5.38 to 8.68; control group, 







Female/male 24/38 21/35 1.00
Mean age (years) 18.23 (0.42) 18.20 (0.40) 0.70
live alone/live with family 48/14 43/13 1.00
Enter the university of first choice 33/29 33/23 0.66




Diagnosis of any anxiety disorder 
in the previous year (yes/no)
7/55 14/42 0.09
BDi-ii (pretreatment) 12.76 (6.66) 13.30 (5.95) 0.64
Note: Values in parentheses represent sD.
Abbreviation: BDi-ii, Beck Depression inventory, second edition.
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mean estimate=12.77, SE=0.88, 95% CI: 11.03 to 14.51; esti-
mate mean difference=5.74, 95% CI: 3.34 to 8.14, P,0.01). 
The effect size (Hedges’ g) for between-group differences 
in 1-year follow-up was -0.87 (95% CI: -1.24 to -0.49).
Next, because this study had missing data, we conducted 
complete case analysis (intervention group, n=51; control 
group, n=49) and then conducted sensitivity analysis and 
examined the discrepancy between ITT and complete case 
analysis. Significant interaction was found between groups 
and times (F value=9.42, degrees of freedom=196, P,0.01; 
Figure 2). Significant difference was found between the 
mean estimates for the intervention group and the con-
trol group at 1-year follow-up (intervention group, mean 
estimate=10.77, SE=0.93, 95% CI: 8.91 to 12.60; control 
group, mean estimate=13.83, SE=0.96, 95% CI: 11.90 to 
15.65; estimated mean difference=3.01, 95% CI: 0.39 to 
5.63, P=0.03). The effect size (Hedges’ g) for between-group 
differences at 1-year follow-up was -0.45 (95% CI: -0.85 
to -0.05). Additionally, a significant difference was found 
in estimated means between the intervention group and the 
control group at posttreatment (intervention group, mean 
estimate=6.45, SE=0.93, 95% CI: 4.62 to 8.29; control group, 
mean estimate=12.77, SE=0.96, 95% CI: 10.95 to 14.69; esti-
mated mean difference=6.37, 95% CI: 3.75 to 8.99, P,0.01). 
The effect size (Hedges’ g) for between-group differences 
at 1-year follow-up was -0.90 (95% CI: -1.33 to -0.51). 
No discrepancy was found between the results of ITT and 
complete case analysis.
Prophylactic effects for onset of MDD
We assessed the significance of differences between the 
intervention group (n=51) and the control group (n=49) 
in developing MDD during the 1-year follow-up. In CIDI, 
participants who met the criteria for MDD responded that 
they had developed depressive symptoms. In addition, par-
ticipants reported the time as 1) within 1 month, 2) between 
2 and 6 months, and 3) between 7 and 12 months after 
baseline assessment.
Two participants in the intervention group developed 
MDD during 1-year follow-up (one participant within the 
previous 1 month, one participant in the previous 2–6 months: 
2/51, 3.92%). Four control group participants developed 
MDD (one participant 2–6 months before, three participants 
7–12 months before: 4/49, 8.16%). Three participants of the 
intervention group and eight participants in the control group 
had an MDD history longer than 1 year before the screening 
of this study. We applied Cox proportional hazard analysis 
to assess differences in survival probabilities between the 
intervention group and the control group. We used the MDD 
Figure 2 changes in BDi-ii score from pretreatment to 1-year follow-up.














Table 2 results of linear mixed model
Intention-to-treat analysis





Estimate (SE) Estimate (SE)
BDi-ii Pretreatment 12.76 (0.83) 13.30 (0.88) -2.93 to 1.89 0.65
Posttreatment 7.03 (0.84) 12.77 (0.88) 3.34 to 8.14 0.00
1-year follow-up 11.00 (0.89) 13.83 (0.91) 0.28 to 5.33 0.03
Complete case analysis





Estimate (SE) Estimate (SE)
BDi-ii Pretreatment 12.63 (0.93) 13.18 (0.96) -2.06 to 3.18 0.65
Posttreatment 6.45 (0.93) 12.77 (0.96) 3.75 to 8.99 0.00
1-year follow-up 10.77 (0.93) 13.83 (0.96) 0.39 to 5.63 0.03
Note: Values in parentheses are ses.
Abbreviations: BDi-ii, Beck Depression inventory, second edition; se, standard error.
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history as a covariate. No significant difference was found 
in these results (χ2=2.51, P=0.11; Figure 3).
Discussion
Results of linear mixed modeling for a repeated measures 
approach show that late adolescent students receiving treat-
ment had significantly different BDI-II scores from those 
of the control group at 1-year follow-up. The effect size for 
between-group differences at 1-year follow-up was -0.41. 
Next, we conducted a complete case analysis and performed 
sensitivity analysis necessary to examine the discrepancy 
between ITT and a complete case analysis. The effect size 
of complete case analysis for between-group differences in 
1-year follow-up was -0.45. Results showed no discrepancy 
between ITT analysis and complete case analysis. Sensitiv-
ity analysis can be done using a different approach to assess 
the robustness of the primary analysis to the chosen method 
for handling missing data.34 Therefore, the primary analy-
sis of this study is regarded as robust. An earlier study, a 
meta-analysis of psychological treatments for subthreshold 
depression, found no significant effect of psychotherapies for 
depressive symptoms between an intervention group and a 
control group at 1-year follow-up.13 An earlier study of col-
lege students found no significant effect for the CBT group 
on depressive symptoms compared to either bibliotherapy 
or brochure controls at either 3- or 6-month follow-up.38 
Results of our earlier report indicated that late adolescents 
with subthreshold depression had a lower frequency of 
environmental rewards than healthy late adolescents.39 Our 
behavioral activation program emphasized increased access 
to positive reinforcement activities to improve the rate of 
response-contingent positive reinforcement. These results 
demonstrate that late adolescent students receiving treatment 
had significantly different BDI-II scores from those of the 
assessment-only control group at 1-year follow-up.
However, the effect size for between-group differences at 
1-year follow-up was -0.41. The effect size of intervention 
can be regarded as small. Our earlier study revealed the effect 
size of behavioral activation program as -0.90 for between-
group differences in acute treatment.19 Therefore, the behav-
ioral activation program effect decreased during 1 year. 
Moreover, we attempted to ascertain whether a 5-week short-
term behavioral activation program can decrease the risk of 
developing MDD compared to a control group or not. Results 
of Cox proportional hazard analysis revealed no significant 
difference between the intervention group and the control 
group in the incidence of MDD. Although a significant 
difference was found in the depressive symptoms at 1-year 
follow-up between the intervention group and the control 
group, one must interpret the results carefully. In terms of the 
considerable reduction in effects between posttreatment and 
follow-up, although some earlier studies conducted booster 
sessions or continuation sessions to maintain the effects of 
intervention,40,41 we conducted no such booster sessions. The 
knowledge that continued support would be provided via 
booster sessions might have reinforced participants’ confi-
dence in managing depression or anxiety.42 An earlier report 
described from a meta-analysis that CBT intervention with 
a booster session is more effective in terms of sustainability 
than CBT interventions without booster sessions.42 To main-
tain behavioral activation effects, it is necessary to review 
activities in booster sessions. Moreover, it is very difficult to 
obtain large effects if baseline depressive symptoms are as 
low as they were in this study. Furthermore, the behavioral 
activation intervention was very brief. It can be regarded as 
a low-intensity intervention. Therefore, long-term effects of 
such treatment might be less likely to be apparent.
Some study limitations are related to the sample used 
for this study. The sample size calculations were conducted 
at the study design stage. However, this sample size was 
based on the study design of an earlier study.19 An earlier 
report described that 200 participants per condition must be 
tested for a difference in the incidence rate.40 Although we 













Figure 3 survival curve.
Notes: survival times are shown for three times. Time 1 is 7–12 months before the 
1-year follow-up period. Time 2 is 2–6 months before the 1-year follow-up period. 
Time 3 is within 1 month from the 1-year follow-up period.
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intervention group and the control group in a preliminary 
study, the sample size of this study was small. A future study 
using a large sample size must be undertaken to examine the 
incidence of MDD. Secondly, in this study, we confirmed 
whether the participants were undergoing psychopharmaco-
logical or psychological treatment in CIDI or not. Participants 
who were not undergoing psychopharmacological or psycho-
logical treatment were included in this study. We confirmed 
the current treatment in this study. Therefore, future studies 
must be conducted to target people who have never received 
psychopharmacological or psychological treatment. Despite 
the limitations described above, the results of this study show 
a significant difference in BDI-II scores between the interven-
tion group and the control group at 1-year follow-up.
Conclusion
Although our behavioral activation program is simple and 
brief, the results obtained at 1-year follow-up indicate a 
significant difference between the BDI-II scores of the late 
adolescent control group students and the students receiving 
treatment. Our 5-week behavioral activation program based on 
behavioral characteristics for subthreshold depression appears 
to be promising for treating subthreshold depression.
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